The Food and Drug Administration (FDA) recently cancelled Johnson & Johnson India’s licence to produce cosmetic products at their Mulund plant.
The
Food and Drug Administration (FDA) recently cancelled Johnson &
Johnson India’s licence to produce cosmetic products at their Mulund
plant. FDA’s order will come into effect from June 24. According to FDA
officials, the order was issued in a case dating back to 2007 when they
found that 15 batches of Johnson & Johnson baby powder were
sterilised by ethylene oxide, a known carcinogenic and irritant.
“While ethylene oxide can be used for sterilisation, the company did
not bother to carry out a test after the process to check the amount of
residue in the product,” said FDA joint commissioner KB Shende, adding
that the company can appeal to the State government before the order
comes into effect.
“The products are used for new born babies.
It is must for the company to follow all measures,” said Shende adding
that the traces of ethylene oxide, if any, should have been measured.
The 15 batches in question consisted of 1,60,000 containers. When Mirror
contacted Johnson & Johnson, the company spokesperson confirmed the
FDA action.
تعليقات
إرسال تعليق